Predicting drug-drug adverse reactions via multi-view graph contrastive representation model

[1]  Fan Yang,et al.  Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships , 2022, PloS one.

[2]  Yongliang Shen,et al.  Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction , 2022, CIKM.

[3]  Shuang Wang,et al.  Molormer: a lightweight self-attention-based method focused on spatial structure of molecular graph for drug-drug interactions prediction , 2022, Briefings Bioinform..

[4]  Qiujie Lv,et al.  Learning size-adaptive molecular substructures for explainable drug–drug interaction prediction by substructure-aware graph neural network , 2022, Chemical science.

[5]  Shaowu Zhang,et al.  Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs , 2022, Molecules.

[6]  Shaowu Zhang,et al.  deepMDDI: A deep graph convolutional network framework for multi-label prediction of drug-drug interactions. , 2022, Analytical biochemistry.

[7]  Hui Yu,et al.  RANEDDI: Relation-aware network embedding for drug-drug interaction prediction , 2022, Inf. Sci..

[8]  Moolchand Sharma,et al.  Drug-Drug Interaction Prediction Based on Drug Similarity Matrix Using a Fully Connected Neural Network , 2021, Proceedings of Second Doctoral Symposium on Computational Intelligence.

[9]  Jian-Yu Shi,et al.  SSI-DDI: substructure-substructure interactions for drug-drug interaction prediction , 2021, Briefings Bioinform..

[10]  Zhongfei Zhang,et al.  Enhancing Drug-Drug Interaction Prediction Using Deep Attention Neural Networks , 2021, bioRxiv.

[11]  Hao Peng,et al.  SUGAR: Subgraph Neural Network with Reinforcement Pooling and Self-Supervised Mutual Information Mechanism , 2021, WWW.

[12]  Xixun Lin,et al.  Bipartite Graph Embedding via Mutual Information Maximization , 2020, WSDM.

[13]  Ping Wang,et al.  Self-Supervised Learning of Contextual Embeddings for Link Prediction in Heterogeneous Networks , 2020, WWW.

[14]  Jiawei Han,et al.  Unsupervised Attributed Multiplex Network Embedding , 2019, AAAI.

[15]  Narjes Rohani,et al.  Drug-Drug Interaction Predicting by Neural Network Using Integrated Similarity , 2019, Scientific Reports.

[16]  Siu-Ming Yiu,et al.  Detecting drug communities and predicting comprehensive drug–drug interactions via balance regularized semi-nonnegative matrix factorization , 2019, Journal of Cheminformatics.

[17]  Yanfang Ye,et al.  Heterogeneous Graph Attention Network , 2019, WWW.

[18]  Yoshua Bengio,et al.  Learning deep representations by mutual information estimation and maximization , 2018, ICLR.

[19]  Andrej Kastrin,et al.  Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning , 2018, PloS one.

[20]  Siu-Ming Yiu,et al.  Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization , 2018, BMC Systems Biology.

[21]  Jure Leskovec,et al.  Modeling polypharmacy side effects with graph convolutional networks , 2018, bioRxiv.

[22]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[23]  Reza Safdari,et al.  Computational prediction of drug-drug interactions based on drugs functional similarities , 2017, J. Biomed. Informatics.

[24]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[25]  Peer Bork,et al.  The SIDER database of drugs and side effects , 2015, Nucleic Acids Res..

[26]  Doheon Lee,et al.  Predicting Pharmacodynamic Drug-Drug Interactions through Signaling Propagation Interference on Protein-Protein Interaction Networks , 2015, PloS one.

[27]  Jianying Hu,et al.  Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side Effects , 2015, Scientific Reports.

[28]  Zhongming Zhao,et al.  Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. , 2014, Journal of the American Medical Informatics Association : JAMIA.

[29]  George Hripcsak,et al.  Similarity-based modeling in large-scale prediction of drug-drug interactions , 2014, Nature Protocols.

[30]  G. De Sarro,et al.  Pharmacokinetic drug-drug interaction and their implication in clinical management , 2013, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[31]  Hongkang Mei,et al.  Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..

[32]  Carol Friedman,et al.  Drug-drug interaction through molecular structure similarity analysis , 2012, J. Am. Medical Informatics Assoc..

[33]  R. Sharan,et al.  INDI: a computational framework for inferring drug interactions and their associated recommendations , 2012, Molecular systems biology.

[34]  D. Bojanic,et al.  Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.

[35]  J. Venitz,et al.  Transient Kinetic and Dynamic Interactions between Verapamil and Dofetilide, a Class III Antiarrhythmic , 2001, Journal of clinical pharmacology.

[36]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[37]  J. Bostwick,et al.  A toxic reaction from combining fluoxetine and phentermine. , 1996, Journal of clinical psychopharmacology.

[38]  Enrique Espinosa,et al.  Possible Vincristine–isoniazid Interaction , 1995, The Annals of pharmacotherapy.

[39]  D. Nierenberg,et al.  The central nervous system serotonin syndrome , 1993, Clinical pharmacology and therapeutics.

[40]  D. Spach,et al.  Rhabdomyolysis associated with lovastatin and erythromycin use. , 1991, The Western journal of medicine.

[41]  M. Flessner,et al.  Prolongation of prothrombin time and severe gastrointestinal bleeding associated with combined use of warfarin and ketoprofen. , 1988, JAMA.

[42]  J. Jolivet,et al.  5-Fluorouracil-metronidazole combination therapy in metastatic colorectal cancer , 1986, Cancer Chemotherapy and Pharmacology.

[43]  V. P. Butler,et al.  Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. , 1981, The New England journal of medicine.

[44]  J. Viikari,et al.  Fenfluramine Therapy in Non-insulin-dependent Diabetic Patients: Effects on Body Weight, Glucose Homeostasis, Serum Lipoproteins, and Antipyrine Metabolism , 1981, Diabetes Care.

[45]  F. Harary,et al.  STRUCTURAL BALANCE: A GENERALIZATION OF HEIDER'S THEORY1 , 1977 .

[46]  M. A. Mergener,et al.  Pharmacokinetics of the Digoxin-Quinidine Interaction via Mixed-Effect Modelling , 1992, Clinical pharmacokinetics.